Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Taizhou Lingfeng Biotechnology Co. Ltd. manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This filing is currently assigned to a distinct art unit, reflecting a specific technical focus for the company's research.
The prosecution is overseen by a distinct examiner, LOUNTOS, GEORGE THEMISTOCLIS. As the busiest examiner for the company, LOUNTOS, GEORGE THEMISTOCLIS is responsible for 1 pending office action. This distribution indicates that the entirety of the company's current pending matters is concentrated under the review of a single individual.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 57.1% | +60.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18795140 | METHODS FOR PREPARING (2S,3R)-P-METHYLSULFONYLPHENYLSERINE | LOUNTOS, GEORGE THEMISTOCLIS | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18795140 | METHODS FOR PREPARING (2S,3R)-P-METHYLSULFONYLPHENYLSERINE | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103 | Final Rejection | — | Pending | Aug 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTaizhou Lingfeng Biotechnology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
George Themistoclis Lountos has the most, with 1 of Taizhou Lingfeng Biotechnology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
